Clinical study on hbig interrupting hbv of mother - infant perpendicular dissemination 乙型肝炎免疫球蛋白阻断乙肝病毒母婴垂直传播临床研究
3.
Conclusion : low - dose im hbig plus lamivudine provides safe and effective long - term prophylaxis against recurrent hbv at < 10 % the cost of the high - dose regimen 结论：低剂量肌注乙型肝炎免疫球蛋白联合拉米夫定的使用为长时间的预防hbv复发提供了安全有效的方案并且可使花费小于大剂量用药方案费用的10 % 。
4.
Methods : australian and new zealand patients who received low - dose hbig plus lamivudine following liver transplantation for hbv - related end - stage liver disease were studied 方法：选择澳洲和新西兰曾接受乙型肝炎免疫球蛋白联合拉米夫定的患者，对这类患者行肝移植后发生的与乙型肝炎病毒相关的末期肝脏疾病进行研究。
